UK starts first vaccine trial, eight weeks into Ebola emergency

The UK has approved clinical trials for a new Ebola vaccine developed by the University of Oxford. The vaccine aims to address the current outbreak in the Democratic Republic of the Congo, which has already claimed over 600 lives.
Why it matters
Rapid vaccine development is essential for containing the Ebola epidemic, which is currently spreading through a volatile conflict zone.
Image source, BBC/Trevor Lloyd Image caption, Researcher Alex Sampson holds the experimental Ebola vaccine
The article provides factual reporting on medical research and public health developments.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in